FZD7 has a critical role in cell proliferation in triple negative breast cancer.
about
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent CancersMammary Development and Breast Cancer: A Wnt PerspectiveFrizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor Complex to Treat CancerTargeting the Wnt pathways for therapiesTargeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28Frizzled homolog proteins, microRNAs and Wnt signaling in cancerNiclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathwayIdentification of Personalized Chemoresistance Genes in Subtypes of Basal-Like Breast Cancer Based on Functional Differences Using Pathway AnalysisOverexpression of microRNA-1 promotes cardiomyocyte commitment from human cardiovascular progenitors via suppressing WNT and FGF signaling pathwaysNewly Constructed Network Models of Different WNT Signaling Cascades Applied to Breast Cancer Expression DataFrizzled 7 expression is positively regulated by SIRT1 and β-catenin in breast cancer cells.WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.GPCRs and cancerCharacterization of Lgr5+ Progenitor Cell Transcriptomes after Neomycin Injury in the Neonatal Mouse CochleaFZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway.Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cellsA unique combination of male germ cell miRNAs coordinates gonocyte differentiation.Wnt signaling in cancerΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling.MiR-199a regulates cell proliferation and survival by targeting FZD7.Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.CDK7-dependent transcriptional addiction in triple-negative breast cancer.A whole-genome RNA interference screen for human cell factors affecting myxoma virus replicationThe C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells.DEAD-box protein p68 is regulated by β-catenin/transcription factor 4 to maintain a positive feedback loop in control of breast cancer progressionDifferential activation of Wnt-β-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner.Mammary cells with active Wnt signaling resist ErbB2-induced tumorigenesisGold(III)-dithiocarbamato peptidomimetics in the forefront of the targeted anticancer therapy: preclinical studies against human breast neoplasia.Wnt modulates MCL1 to control cell survival in triple negative breast cancer.Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers.Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expressionTranscriptome analysis of Wnt3a-treated triple-negative breast cancer cells.The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor.β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells.Microvascular invasion in hepatocellular carcinoma overexpression promotes cell proliferation and inhibits cell apoptosis of hepatocellular carcinoma via inhibiting miR-199a expressionTargeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advancesDeveloping and characterization of single chain variable fragment (scFv) antibody against frizzled 7 (Fzd7) receptor.Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling.JDINAC: joint density-based non-parametric differential interaction network analysis and classification using high-dimensional sparse omics data.
P2860
Q26739665-BF8BD19E-8CE6-4931-866E-5B95E8EB509AQ26740086-12E4DE6B-398A-41C1-BED5-8C849C7A923EQ26747651-B85B5174-6242-4844-AB5A-5ECA1B8D19DAQ26821978-BEEC865A-C9AB-4D08-A578-D850303989FAQ26991723-41105689-BC46-462F-B00B-796A2C5D3325Q27010132-F5ED7616-6614-4A57-A66C-72DBFC883702Q28478466-38B0EDB6-D17C-4B81-B566-046D9014961CQ28545978-1E3E5A93-4C04-4662-AAFE-E4DF7B318F4AQ28854604-87D463F7-B647-461E-A76F-50D8EAF29C0BQ31030029-FFCCAB1E-87CC-42DA-B3F4-965887E971CCQ33712564-04DFC95A-BBF2-4AFF-9922-9D1C54990C31Q33808166-1F7D6C4D-82FF-4A06-BD76-04D347AB84E9Q33828719-604BAC01-6597-423D-A2D4-CB77199143D8Q33869949-626D92EB-2C4E-4BAD-A3D4-85731A473D13Q34007808-E22077C3-9680-49C9-A3D2-8A0B07C5A2A5Q34052780-C1DDB7BF-F691-4325-9DE6-7B9A3DC6E857Q34247366-A32656D7-C762-49AA-9F1F-B96AEE2DD8FAQ34262857-48B33972-1F76-4888-9BB0-51B8F25F170EQ34283057-56D0D68E-3740-4D37-A81B-095B4607FEE7Q34338509-E55DB800-8424-4DC7-A9AC-E721E9227F65Q34492498-30235B35-2B57-4A9A-8A59-3D8D9AAA0D79Q34495729-25D5285C-E3C1-4FF0-8FEA-CCC4E1EE355EQ34585582-873A392A-2183-498A-9FC9-0EF74F7E8784Q34612838-434DB12E-8A9D-4809-AB5C-184B0ABAFE76Q35021360-07C63024-2CB4-42B0-B2C3-A348B71C8E97Q35021758-A87D3526-827C-4FD9-AF19-2249BE6F7BF6Q35050344-366268A9-D54E-4924-81C5-B2624C724BA5Q35083349-D7F0108B-3991-45E7-961B-2F6D7CB90860Q35101885-8B109E34-D2DB-4146-AE6F-23896697765DQ35176109-00187D47-BFBE-4E86-BC6B-521A25A7B4C6Q35179788-76DFB321-6A79-435B-B5D5-134DEA017471Q35300556-2D17074D-DF59-4533-A19C-D0A47EB54C01Q35793711-45228746-7C11-49BD-A7C2-B2DCE75060B8Q35930626-D1343852-9F53-46E7-84A8-C4AA1D649B8CQ36015140-B9BBFC3B-76A3-49F4-B7F0-A5DB95218C13Q36157045-1C8CC491-2C64-45BB-B244-F75A96EE719EQ36193805-2E33F64E-039F-4E5D-B8E4-CEC7744F79A0Q36303639-CFABA8D2-93D1-48F8-A91F-C914F08A3CA5Q36329477-1A0AA835-C9AF-45D6-BBFC-C870A49BED03Q36393065-6D197EC9-A02B-48D0-95A8-58D2A9B62FD9
P2860
FZD7 has a critical role in cell proliferation in triple negative breast cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
FZD7 has a critical role in cell proliferation in triple negative breast cancer.
@en
FZD7 has a critical role in cell proliferation in triple negative breast cancer.
@nl
type
label
FZD7 has a critical role in cell proliferation in triple negative breast cancer.
@en
FZD7 has a critical role in cell proliferation in triple negative breast cancer.
@nl
prefLabel
FZD7 has a critical role in cell proliferation in triple negative breast cancer.
@en
FZD7 has a critical role in cell proliferation in triple negative breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
FZD7 has a critical role in cell proliferation in triple negative breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2011.145
P407
P577
2011-05-02T00:00:00Z